The NSW Drug Discovery Forum is an annual event that bridges the gap between groundbreaking academic research and commercialisation pathways. We enable participating researchers learn more about the full potential of their work and springboard bench-top discoveries pharmaceutical uptake.

Since the launch of the Forum in 2023, panellists have represented national and global companies including Brandon Capital, Syntara, Axelia Oncology, Uniseed, Ab-Initio Pharma, IP Group, CSL, Proto Axiom, Skin2Neuron, ProPharma and Tenmile.

We bring together over a hundred experts from academia, healthcare, government and industry.

Researchers based in NSW have the opportunity pitch cutting-edge ideas to biotech and investment professionals.

Delivered through a dynamic live feedback format; leading discussions in specific translation hurdles.



The latest news